Dr. Dakhil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
818 N Emporia, Ste 403
Wichita, KS 67214Phone+1 316-262-4467Fax+1 316-262-0706
Summary
- Dr. Christopher Dakhil is an oncologist in Wichita, KS and is affiliated with multiple hospitals in the area, including Wesley Healthcare Center, Via Christi Hospital on St. Francis, Kansas Heart Hospital, and Wesley Woodlawn Hospital & ER. He received his medical degree from University of Kansas School of Medicine and has been in practice 11 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, breast cancer, myelodysplasia, and myelofibrosis.
Education & Training
University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012- University of Kansas School of MedicineResidency, Internal Medicine, 2006 - 2009
- University of Kansas School of MedicineClass of 2006
Certifications & Licensure
KS State Medical License 2009 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Internal Medicine Intern of the Year University of Kansas, 2007
- Delp Award for Outstanding Medical Student Performance in Internal Medicine 2006
Publications & Presentations
PubMed
- 80 citationsBlood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial.Edward S Kim, Vamsidhar Velcheti, Tarek Mekhail, Cindy Yun, Sarah M Shagan
Nature Medicine. 2022-05-01 - 5 citationsAndrogen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small ...Jennifer Le-Rademacher, Kendrith M. Rowland, Pamela J. Atherton, Christopher S R Dakhil, Zhifu Sun
The American Journal of Hospice & Palliative Care. 2019-01-02 - 20 citationsAPF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapyIan D. Schnadig, Richy Agajanian, Christopher Dakhil, Nashat Y. Gabrail, Robert E. Smith
Future Oncology. 2016-03-21
Abstracts/Posters
- Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant.Anup K. Kasi, Christopher Dakhil, and Nisreen Haideri, Kansas ACP Conference
Lectures
- Skin Cancers.Kansas City VA Medical Center, Nursing Educational Series
- Workup of Anemia.University of Kansas Internal Medicine Core Conference Lecture Series
- Platelet Disorders.University of Kansas Internal Medicine Core Conference Lecture Series
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
